FIELD: medicine, pharmaceutics.
SUBSTANCE: group of inventions relates to medicine and describes a composition of digestive enzymes which contains granules covered with an enterosoluble coating, which contain a digestive enzyme, and digestive enzyme-containing granules, which are not covered with a coating, where the granules covered with the enterosoluble coating, which contain the digestive enzyme, contain a core and the enterosoluble coating, located on the core, where the core contains a therapeutically effective quantity of lipase, and the enterosoluble coating contains an enterosoluble polymer; and the digestive enzyme-containing granules, which are not covered with a coating, contain a therapeutically effective quantity of protease and in fact do not contain the enterosoluble polymer coating; where the lipase activity of the coating-covered granules is in the range from approximately 1000 USP units to approximately 10000 USP units, and protease activity in the granules which are not covered with the coating is in the range from approximately 65000 USP units to approximately 34000 USP units. Also methods of treating pain in case of pancreatitis and pancreas insufficiency, as well as a method for the treatment of exocrine insufficiency of the pancreas are described.
EFFECT: group of inventions makes it possible to achieve an effective and safe clinical result in a low dose.
16 cl, 20 tbl, 10 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR DISSOLUTION TESTING OF SOLID COMPOSITIONS CONTAINING DIGESTIVE ENZYMES | 2012 |
|
RU2602183C2 |
DIGESTIVE ENZYME COMPOSITION SUITABLE FOR ENTERAL ADMINISTRATION | 2014 |
|
RU2679832C2 |
HIGH POTENCY PANCREATIN PHARMACEUTICAL COMPOSITIONS | 2014 |
|
RU2686460C2 |
COMPOSITION CONTAINING DIGESTIVE ENZYMES AND NUTRIENTS SUITABLE FOR ENTERAL ADMINISTRATION | 2014 |
|
RU2651458C2 |
COMPOSITIONS CONTAINING LIPASE, PROTEASE AND AMYLASE INTENDED FOR TREATMENT OF PANCREATIC INSUFFICIENCY | 2005 |
|
RU2385736C2 |
STABLE COMPOSITIONS OF DIGESTIVE ENZYMES | 2008 |
|
RU2445952C2 |
CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS UNSTABLE IN MEDICINAL ACID MEDIUM | 2006 |
|
RU2440101C2 |
METHODS OF TREATING BEHAVIORAL SYMPTOMS OF NEUROLOGICAL AND MENTAL DISORDERS | 2013 |
|
RU2654230C2 |
PANCREATINE MICROPELLET NUCLEI TO BE ENTERO-SOLUBLE COATED | 2006 |
|
RU2408364C2 |
PROTEASES FOR PHARMACEUTICAL APPLICATION | 2006 |
|
RU2420578C2 |
Authors
Dates
2015-12-10—Published
2010-09-17—Filed